Key result
This review summarizes the pathophysiologic contributions of the renin-angiotensin system in hypertension and its possible correlation with poor outcomes in hypertensive patients with COVID-19.
Why the study?
Mortality from COVID-19 is high in hypertensive patients, but the role of components of the renin-angiotensin system beyond ANG II requires elucidation.
Design
Review
Authors
Loading...
May guide RAS research in hypertensive COVID-19; leaves open practice implications without prospective data.
This review highlights the potential role of the renin-angiotensin system, particularly angiotensin II and ACE2, in the pathogenesis and worsening of COVID-19 in hypertensive patients.
Silva‐Aguiar et al. (2020) conducted a review in COVID-19 and hypertension. Renin-angiotensin system components was evaluated. This review summarizes the pathophysiologic contributions of the renin-angiotensin system in hypertension and its possible correlation with poor outcomes in hypertensive patients with COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: